The DOI matches its Crossref record; 336 of the 343 references it cites were found in a registry or an index.
Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
Open accessAbstract
Breast cancer (BC) is one of the most prevalent cancers in women worldwide. Limited specificity, systemic toxicity, risk of recurrence, and drug resistance are some of the drawbacks of traditional BC treatment approaches. Therefore, it is crucial to develop more effective, safe, and customized management plans for BC. The application of nanoparticle-based systems, such as liposomes, nanostructured lipid carriers, polymeric micelles, polymeric nanoparticles, dendrimers, and hybrid nanoparticles, has drawn significant interest in BC treatment. Nanomedicine can enhance the efficacy of drugs through active targeting, better tissue penetration, and more efficient tumor suppression via improved retention and permeability. Additionally, gene delivery using hybrid and theranostic nanomedicine has also been explored in BC treatment. Numerous nanomedicines have been used clinically for the treatment of breast cancer, some of which have already received U.S. Food and Drug Administration (USFDA) approval. Here, we focus on nanotechnology-based therapeutic approaches for BC treatment and highlighted their enhanced efficacy and reduced side effects. In addition, we have also explored on the possible utilization of Artificial Intelligence (AI) nanomedicine and bioinspired nanocarriers for BC treatment, which could pave the way for more precise, effective, and personalized therapies by improving nanoparticle design, optimizing drug delivery systems, and leveraging big data analytics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The route of administration also remains a practical limitation, as intratumoral delivery may not be feasible for all anatomical sites, whereas systemic administration raises concerns regarding off-target accumulation and toxicity [25,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [97]
In the citing paper
“Many preclinical studies rely on passive targeting through the enhanced permeability and retention (EPR) effect, which is highly variable and generally less pronounced in human tumors than in experimental models [5,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [97]
In the citing paper
“These systems established the proof-of-concept that nanomaterials could enhance radiation-induced damage, but they also highlighted important limitations related to tumor hypoxia, antioxidant defenses, heterogeneous intratumoral distribution, and variable nanoparticle accumulation [11,12,25,95,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [97]
In the citing paper
“Although these combinatorial systems often demonstrate enhanced efficacy experimentally, their clinical development is challenged by issues related to reproducibility, manufacturing consistency, regulatory approval, scalability, and long-term safety [25,96,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [97]
Citations
Cites
Items 201–336 of 336
Quantum Dot Research in Breast Cancer: Challenges and Prospects
Omidian, H., Wilson, R. L., & Cubeddu, L. X. (2024) · Materials · doi:10.3390/ma17092152 · Cited by 43
Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force
Wang, Z., Zhi, K., Ding, Z., Sun, Y., Li, S., Li, M., Pu, K., & Zou, J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.012 · Cited by 42
Selective organ targeting nanoparticles: from design to clinical translation
Li, J., & Wang, H. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00145h · Cited by 42
Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents
Zhang, H., Liu, X., & Fan, H. M. (2023) · Nano Research · doi:10.1007/s12274-023-6214-9 · Cited by 42
Jayeoye, T. J., Eze, F. N., Singh, S. K., Prajapati, B. G., Kapoor, D. U., & Muangsin, N. (2024) · BioNanoScience · doi:10.1007/s12668-024-01436-7 · Cited by 42
Eskiler, G. G., Çeçener, G., Egelí, Ü., & Tunca, B. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2502-6 · Cited by 42
De, A., Roychowdhury, P., Bhuyan, N. R., Ko, Y. T., Singh, S. K., Dua, K., & Kuppusamy, G. (2023) · Molecules · doi:10.3390/molecules28031393 · Cited by 42
Samson, A. A. S., Park, S.-J., Kim, S., Min, D., Jeon, N. L., & Song, J. M. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2017.1420081 · Cited by 41
Nanomedicine Scale-Up Technologies: Feasibilities and Challenges
Patel, D. M., Patel, N. N., & Patel, J. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-50703-9_24 · Cited by 41
Janiszewska, J., Posadas, I., Játiva, P., Bugaj, M., Urbańczyk-Lipkowska, Z., & Ceña, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165704 · Cited by 41
Structure–Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles
Yang, Y., Li, X., Song, J., Li, L., Ye, Q., Zuo, S., Liu, T., Dong, F., Liu, X., He, Z., et al. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04976 · Cited by 40
Dhiman, R., Bazad, N., Mukherjee, R., Himanshu, Gunjan, Leal, E., Ahmad, S., Kaur, K., Raj, V. S., Chang, C.-M., et al. (2024) · Discover Nano · doi:10.1186/s11671-024-04086-6 · Cited by 40
Ligand conjugated lipid‐based nanocarriers for cancer theranostics
Kumar, R., Dkhar, D. S., Kumari, R., divya, D. D., Mahapatra, S., Srivastava, A., Dubey, V. K., & Chandra, P. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28205 · Cited by 39
Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment
Sia, C. S., Lim, H. P., Tey, B. T., Goh, B. H., & Low, L. E. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188779 · Cited by 39
Kutlehria, S., Behl, G., Patel, K. R., Doddapaneni, R., Vhora, I., Chowdhury, N., Bagde, A., & Singh, M. S. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0885-z · Cited by 38
A Review on Targeting Nanoparticles for Breast Cancer
Alqaraghuli, H. G. J., Kashanian, S., & Rafipour, R. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190731130001 · Cited by 38
Exploring the unexplored avenues of surface charge in nano-medicine
Shah, S., Rangaraj, N., Singh, S. B., & Srivastava, S. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100406 · Cited by 38
Iqbal, H., Razzaq, A., Khan, N. U., Rehman, S. U., Webster, T. J., Xiao, R., & Menaa, F. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213039 · Cited by 37
Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics
Sarkar, M., Wang, Y., Ekpenyong, O., Liang, D., & Xie, H. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1846 · Cited by 37
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
Dissanayake, R. K., Towner, R. A., & Ahmed, M. (2023) · Cancers · doi:10.3390/cancers15112906 · Cited by 37
Sun, S., Wang, Y.-H., Gao, X., Wang, H.-Y., Zhang, L., Wang, N., Li, C., & Xiong, S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1253048 · Cited by 37
NAYEK, S., Raghavendra, N. M., & Kumar, B. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102073 · Cited by 36
Zhou, P., Liang, X., Zhou, C., Qin, J., Hou, C., Zhu, Z., Zhang, W., Wang, S., & Zhong, D. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01225g · Cited by 35
Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier
Omidi, Y., Kianinejad, N., Kwon, Y. M., & Omidian, H. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1887729 · Cited by 35
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
Tang, L. Y., Jiang, W., Wu, L., Yu, X., He, Z., Shan, W., Fu, L., Zhang, Z., & Zhao, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s335405 · Cited by 35
Lin, G., Huang, J., Zhang, M., Chen, S., & Zhang, M. (2022) · Nanomaterials · doi:10.3390/nano12040584 · Cited by 35
Evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment
Verma, R., Singh, V., Koch, B., & Kumar, M. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113308 · Cited by 35
Oncologic anthropology: Global variations in breast cancer risk, biology, and outcome
Newman, L. A. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27459 · Cited by 35
Application of artificial intelligence in cancer diagnosis and tumor nanomedicine
Wang, J., Liu, G., Zhou, C. P., Cui, X., Wang, W., Wang, J., Huang, Y., Jiang, J., Wang, Z., Tang, Z., et al. (2024) · Nanoscale · doi:10.1039/d4nr01832j · Cited by 35
Aravindan, A., Gupta, A., Moorkoth, S., & Dhas, N. L. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106007 · Cited by 35
Anticancer potential of gold nanoparticles (AuNPs) using a battery of in vitro tests
Alafaleq, N. O., Alomari, A., Khan, M. S., Shaik, G. M., Hussain, A., Ahmed, F., Hassan, I., Alhazza, I. M., Alokail, M. S., Alenad, A. M. H., et al. (2022) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0502 · Cited by 35
Self-citationLipid-based nanoparticulate delivery systems for HER2-positive breast cancer immunotherapy
Behravan, N., Zahedipour, F., Jaafari, M. R., Johnston, T. P., & Sahebkar, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120294 · Cited by 34
Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics
Kesharwani, P., Chadar, R., Shukla, R., Jain, G. K., Aggarwal, G., Abourehab, M. A. S., & Sahebkar, A. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2103627 · Cited by 34
Alserihi, R. F., Mohammed, M. R. S., Kaleem, M., Khan, M. I., Sechi, M., Zughaibi, T. A., & Tabrez, S. S. M. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102627 · Cited by 34
Self-citationPiccolo, M., Ferraro, M. G., Raucci, F., Riccardi, C., Saviano, A., Krauss, I. R., Trifuoggi, M., Caraglia, M., Paduano, L., Montesarchio, D., et al. (2021) · Cancers · doi:10.3390/cancers13205164 · Cited by 33
Srivastava, S., Kumar, A., Yadav, P. K., Kumar, M., Mathew, J., Pandey, A. C., & Chourasia, M. K. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.2007394 · Cited by 33
Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclib
Shirani, S., Varshosaz, J., Rostami, M. R., & Mirian, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.095 · Cited by 33
Xu, H., Zuo, S., Wang, D., Zhang, Y., Li, W., Li, L., Liu, T., Yu, Y., Lv, Q., He, Z., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.012 · Cited by 33
Sadr, S., Rahdar, A., Pandey, S., Hajjafari, A., Soroushianfar, M., Sepahvand, H., Sasani, B., Kavasebi, S. S., & Borji, H. (2024) · BioNanoScience · doi:10.1007/s12668-024-01639-y · Cited by 33
Folic acid‐conjugated raloxifene hydrochloride carbon nanotube for targeting breast cancer cells
Natarajan, J., De, A., Jubee, S., & Ekkuluri, S. (2019) · Drug Development Research · doi:10.1002/ddr.21620 · Cited by 33
Thakur, C. K., Neupane, R., Karthikeyan, C., Ashby, C. R., Babu, R. J., Boddu, S. H. S., Tiwari, A. K., & Moorthy, N. S. H. N. (2022) · Molecules · doi:10.3390/molecules27217461 · Cited by 33
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
da Silva, G. H. R., de Moura, L. D., de Carvalho, F. V., Gerônimo, G., Mendonça, T. C., de Lima, F. F., & de Paula, E. (2021) · Molecules · doi:10.3390/molecules26226929 · Cited by 32
Harnessing the power of green synthesis of nanomaterials for anticancer applications: A review
Holghoomi, R., Kharaba, Z. J., Rahdar, A., Pandey, S., & Ferreira, L. F. R. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215903 · Cited by 32
Zolbanin, N. M., Jafari, R., Majidi, J., Atyabi, F., Yousefi, M., Jadidi‐Niaragh, F., Maleki, L. A., Shanehbandi, D., Soltani‐Zangbar, M. S., & Nayebi, A. M. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.045 · Cited by 32
New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer
Ahmed, M., Daoud, G. H., Mohamed, A., & Harati, R. (2021) · Genes · doi:10.3390/genes12050723 · Cited by 31
Nanomedicine-based immunotherapy for Alzheimer's disease
Hoque, M., Samanta, A., Alam, S. S. M., Zughaibi, T. A., Kamal, M. A., & Tabrez, S. S. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104973 · Cited by 31
Self-citationKunachowicz, D., Kłosowska-Buryło, K., Sobczak, N., & Kepinská, M. (2024) · Nanomaterials · doi:10.3390/nano14171424 · Cited by 31
Mekseriwattana, W., Phungsom, A., Sawasdee, K., Wongwienkham, P., Kuhakarn, C., Chaiyen, P., & Katewongsa, K. P. (2021) · Photochemistry and Photobiology · doi:10.1111/php.13464 · Cited by 31
Emami, A., Ghafouri, H., & Sariri, R. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122976 · Cited by 30
Zhou, X., Xu, X., Hu, Q., Wu, Y. L., Yu, F., He, C., Qian, Y., Han, Y., Tang, J., & Hu, H. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01855a · Cited by 29
Farrokhi, F., Karami, Z., Esmaeili‐Mahani, S., & Heydari, A. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.08.015 · Cited by 29
Suksiriworapong, J., Pongprasert, N., Bunsupa, S., Taresco, V., Crucitti, V. C., Janurai, T., Phruttiwanichakun, P., Sakchaisri, K., & Wongrakpanich, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061771 · Cited by 29
Liposomes: Ideal drug delivery systems in breast cancer
Forouhari, S., Beygi, Z., Mansoori, Z., Hajsharifi, S., Heshmatnia, F., & Hayat, S. M. G. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2253 · Cited by 28
Makeen, H. A., Mohan, S., Al-Kasim, M. A., Sultan, M. H., Albarraq, A. A., Ahmed, R. A., Alhazmi, H. A., & Alam, M. I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071086 · Cited by 28
Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers
Thiruchenthooran, V., Świtalska, M., Bonilla-Vidal, L., Espina, M., García, M. L., Wietrzyk, J., Sánchez‐López, E., & Gliszczyńska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911310 · Cited by 28
Wróbel, A., & Drozdowska, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191016151018 · Cited by 27
Some Nanocarrier’s Properties and Chemical Interaction Mechanisms with Flavones
Espíndola, C. (2023) · Molecules · doi:10.3390/molecules28062864 · Cited by 27
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer
Kitsios, K., Sharifi, S., & Mahmoudi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00044 · Cited by 27
DeVeaux, S. A., & Gomillion, C. T. (2019) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-018-0089-4 · Cited by 27
Singh, D. D., Verma, R. P., Tripathi, S. K., Sahu, R., Trivedi, P., & Yadav, D. K. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210902120754 · Cited by 27
Badea, M. A., Balaș, M., Prodana, M., Cojocaru, F., Ioniță, D., & Dinischiotu, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020469 · Cited by 26
Wang, Y., Pasternak, M. M., Sathiyamoorthy, K., & Kolios, M. C. (2021) · Biomedical Optics Express · doi:10.1364/boe.419252 · Cited by 25
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Ibrahim, A. A., Nsairat, H., Al-Sulaibi, M., El‐Tanani, M., Jaber, A. M., Lafi, Z. M., Barakat, R., Abuarqoub, D. A., Mahmoud, I. S., Obare, S. O., et al. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2343882 · Cited by 25
Naseem, N., Kushwaha, P., & Haider, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03408-w · Cited by 25
Gupta, U., Saren, B. N., Khaparkhuntikar, K., Madan, J., & Singh, P. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.034 · Cited by 25
Srivastava, N., Mishra, Y., Mishra, V. K., Ranjan, A., & Tambuwala, M. M. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230510094850 · Cited by 24
Alipour, B., Mortezazadeh, T., Abdulsahib, W. K., Arzhang, A., Malekzadeh, R., & Farhood, B. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104682 · Cited by 24
Cutting-edge tumor nanotherapy: Advancements in 5-fluorouracil Drug-loaded chitosan nanoparticles
Karami, M. H., & Abdouss, M. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.112430 · Cited by 24
Bjørnstad, R., Reiten, I. N., Knudsen, K. S., Schjøtt, J. D., & Herfindal, L. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122379 · Cited by 23
Enhancing biomedical imaging: the role of nanoparticle-based contrast agents
Habeeb, M., Vengateswaran, H. T., Tripathi, A. K., Kumbhar, S. T., You, H. W., & Hariyadi (2024) · Biomedical Microdevices · doi:10.1007/s10544-024-00725-y · Cited by 23
Liu, F., Li, L., Lan, M., Zou, T., Kong, Z., Cai, T., Wu, X. Y., & Cai, Y. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0241 · Cited by 23
Zeng, B., Pian, L., Liu, Y., Wang, S., Wang, N., Liu, C., Wu, H., Wan, H., Chen, L., Huang, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02838-1 · Cited by 23
Recent Advances in Targeted Nanotherapeutic Approaches for Breast Cancer Management
Gupta, P., Neupane, Y. R., Parvez, S., & Kohli, K. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0281 · Cited by 22
Passos, J. S., Dartora, V. F. C., Salata, G. C., Malagó, I. D., & Lopes, L. B. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122681 · Cited by 22
Masnavi, M., Pourmadadi, M., Abdouss, M., Rahdar, A., Fathi‐karkan, S., & Pandey, S. (2024) · BioNanoScience · doi:10.1007/s12668-024-01593-9 · Cited by 22
Musumeci, T., Bonaccorso, A., & Carbone, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00018-3 · Cited by 22
Aekrungrueangkit, C., Wangngae, S., Kamkaew, A., Ardkhean, R., Thongnest, S., Boonsombat, J., Ruchirawat, S., & Khotavivattana, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-17625-x · Cited by 21
Liu, M., Chen, X., Chen, H., Wu, X., Fan, W., & Chen, J. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500860 · Cited by 21
Aptamer-functionalized liposomes for targeted cancer therapy
Moosavian, S. A., Kesharwani, P., Singh, V., & Sahebkar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00014-2 · Cited by 21
Badr-Eldin, S. M., Aldawsari, H. M., Fahmy, U. A., Ahmed, O. A. A., Alhakamy, N. A., Al-hejaili, O. D., Alhassan, A. A., Ammari, G. A., Alhazmi, S. I., Alawadi, R. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169440 · Cited by 21
Lipid‐Based Nanocarriers as Drug Delivery System and Its Applications
Jain, V. K., Kumar, H., Chand, P., Jain, S., & P, P. S. (2021) · doi:10.1002/9781119711698.ch1 · Cited by 20
Cabazitaxel-nano delivery systems as a cutting-edge for cancer therapy
Pourmadadi, M., Ghaemi, A., Shaghaghi, M., Rahdar, A., & Pandey, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104338 · Cited by 20
Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy
Huang, C., Chang, E., Zheng, L., Raj, J. G. J., Wu, W. E., Pisani, L. J., & Daldrup-Link, H. E. (2023) · Theranostics · doi:10.7150/thno.79342 · Cited by 20
Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer
Munive, M. L., Vazquez-Lopez, M. I., & García‐López, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910712 · Cited by 20
Kedar, P., Saraf, A., Maheshwari, R., & Sharma, M. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00856 · Cited by 20
Rajeshkumar, R. R., Pavadai, P., Panneerselvam, T., Deepak, V., Pandian, S. R. K., Kabilan, S. J., Vellaichamy, S., Jeyaraman, A., Kumar, A., Sundar, K., et al. (2023) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-023-02480-y · Cited by 19
Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine
Aulić, S., Marson, D., Laurini, E., Fermeglia, M., & Pricl, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820016-2.00016-1 · Cited by 18
Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism
Malik, Z., Parveen, R., Abass, S., Dar, M. I., Husain, S. A., & Ahmad, S. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220416213639 · Cited by 18
Lithocholic acid conjugated mPEG-b-PCL micelles for pH responsive delivery to breast cancer cells
Işık, G., Kızıltay, A., Hasırcı, N., & Tezcaner, A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121779 · Cited by 18
Kaleem, M., Thool, M., Dumore, N. G., Abdulrahman, A. O., Ahmad, W., Almostadi, A., Alhashmi, M. H., Kamal, M. A., & Tabrez, S. S. M. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1440430 · Cited by 18
Self-citationSohail, M., Yu, B., Sun, Z., Liu, J., Li, Y., Zhao, F., Chen, D., Yang, X., & Xu, H. Z. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2073403 · Cited by 18
Theranostic RGD@Fe3O4-Au/Gd NPs for the targeted radiotherapy and MR imaging of breast cancer
Amraee, A., Alamzadeh, Z., Irajirad, R., Sarikhani, A., Ghaznavi, H., Harvani, H. G., Mahdavi, S. R., Shirvalilou, S., & Khoei, S. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00214-6 · Cited by 17
Evolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine
Afzal, M. Z., & Vahdat, L. T. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070719 · Cited by 17
Ambre, P., Gupta, C. R., Naik, I., Menon, M., & Coutinho, E. C. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220408095510 · Cited by 16
Akinoglu, E. M., Özbilgin, K., Sönmez, P. K., Özkut, M. M., Giersig, M., İnan, S., Gümüştepe, E., & Kurtman, C. (2017) · Progress in Biomaterials · doi:10.1007/s40204-017-0078-6 · Cited by 16
Sezer, C. V. (2021) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20191025131008 · Cited by 16
Severe adverse reactions caused by omeprazole: A case report
Yu, M., Qian, J., Guo, D., Li, L., & Liu, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3444 · Cited by 16
Terpenes and Terpenoids Conjugated with BODIPYs: An Overview of Biological and Chemical Properties
Stanková, J., Jurášek, M., Hajdúch, M., & Džubák, P. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00961 · Cited by 16
Rajaei, M., Rashedi, H., Yazdian, F. A., Pourmadadi, M., Rahdar, A., & Pandey, S. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100172 · Cited by 15
Chen, J., Lv, M., Su, X., Wang, S., Wang, Y., Fan, Z., Zhang, L., & Tang, G. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s374293 · Cited by 15
Mezghrani, B., Ali, L. M. A., Cubedo, N., Rossel, M., Hesemann, P., Durand, J., & Bettache, N. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123083 · Cited by 14
How Are Natural-Based Polymers Shaping the Future of Cancer Immunotherapy—A Review
Rodrigues, D. B., Reis, R. L., & Pirraco, R. P. (2023) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583724.2023.2234462 · Cited by 14
Manufacturing Techniques for Nanoparticles in Drug Delivery
Real, D. A., Formica, M. L., Picchio, M. L., & Paredes, A. J. (2021) · CRC Press eBooks · doi:10.1201/9781003168584-2 · Cited by 14
Karahaliloğlu, Z., Kılıçay, E., & Hazer, B. (2022) · Journal of Biomaterials Applications · doi:10.1177/08853282211065085 · Cited by 12
Polymeric Nanomaterials: Fundamentals and Therapeutic Applications
Maji, I., Mahajan, S., Sriram, A., Mehra, N. K., & Singh, P. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-30529-0_2 · Cited by 12
Baskaran, S., Siew, Q. Y., Tan, M. T. T., & Loh, H. (2024) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqae003 · Cited by 12
Kaplan, H. M., & Pazarcı, P. (2024) · ACS Omega · doi:10.1021/acsomega.3c07624 · Cited by 12
Exosomes and breast cancer angiogenesis; Highlights in intercellular communication
Khanicheragh, P., Abbasi‐Malati, Z., Saghebasl, S., Hassanpour, P., Milani, S. Z., Rahbarghazi, R., & Hasani, A. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03606-9 · Cited by 12
Rathee, J., Kanwar, R., Kumari, L., Pawar, S. V., Sharma, S., Ali, M. E., Salunke, D. B., & Mehta, S. K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2037465 · Cited by 12
Nanomedicine: next generation modality of breast cancer therapeutics
Thorat, N. D., & Bauer, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820016-2.00001-x · Cited by 10
Carrese, B., Cavallini, C., Armanetti, P., Silvestri, B., Calı̀, G., Luciani, G., Sanità, G., Menichetti, L., & Lamberti, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417374 · Cited by 10
Lipid-based Nanocarrier Drug Delivery Approach for Biomedical Application
Upadhyay, P., Aslam, R., Tiwari, V., & Upadhyay, S. (2023) · Current Nanomaterials · doi:10.2174/2405461508666230508140508 · Cited by 10
Quantum Dots in Biosensing, Bioimaging, and Drug Delivery
Mondal, S., & Pan, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-3144-4_9 · Cited by 9
Boratto, F., Lages, E. B., Loures, C. M. C., Sabino, A. D. P., Malachias, Â., Townsend, D. M., de Barros, A. L. B., Ferreira, L. A. M., & Leite, E. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115034 · Cited by 9
Barkat, M. A., Rahman, M., Alharbi, K. S., Altowayan, W. M., Alrobaian, M., Afzal, O., Altamimi, A. S. A., Alhodieb, F. S., Almalki, W. H., Choudhry, H., et al. (2022) · Journal of Cluster Science · doi:10.1007/s10876-022-02332-4 · Cited by 9
Fundamental Considerations of Targeted Drug Therapies for Breast Cancer
Castillo‐Tobías, I., Berlanga, L., Poblano, J., Rodríguez‐Salazar, M. D. C., Aguayo‐Morales, H., & Cobos-Puc, L. E. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040043 · Cited by 9
Inorganic Material‐Based Nanocarriers for Delivery of Biomolecules
Shariatinia, Z. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch26 · Cited by 9
Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model
Hu, Y., Wang, D., Zhang, T., Lei, M., Luo, Y., Chen, Z., Li, Y., Duan, D., Zhang, L., & Zhu, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s449042 · Cited by 8
Transdermal therapeutic systems in breast cancer therapy
Fan, M., Zheng, J., Huang, Y. M., Lu, H., & Lu, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105139 · Cited by 8
Surve, C., Banerjee, A. T., Anupriya, S., Chakraborty, R., Kumar, D., Butti, R., Gorain, M., Parida, S., Kundu, G. C., Shidhaye, S. S., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0446 · Cited by 7
PEGylation as a Tool to Alter Immunological Properties of Nanocarriers
Tiwari, A., Goswami, S., Joshi, M., Gandhi, S., Soni, P., Tekade, M., Mule, S. R., & Tekade, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_6 · Cited by 7
Targeted Drug Delivery with Lipid-based Nanoparticles: Innovations for Improved Cancer Therapy
Saha, A., Chauhan, S. B., & Singh, I. (2024) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812316387240822075859 · Cited by 6
An update on selective estrogen receptor modulator: repurposing and formulations
Patel, R., James, V., & Prajapati, B. G. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03753-w · Cited by 6
In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer
Sahib, A. S., Wennas, O. N., Mahdi, B. W., & abood, R. M. A. (2022) · Pharmacia · doi:10.3897/pharmacia.69.e85390 · Cited by 6
Liu, H., Liu, Y., Li, N., Zhang, G., & Wang, M. (2023) · PubMed · doi:10.19540/j.cnki.cjcmm.20230410.301 · Cited by 6
Nanotechnology advances in breast cancer
Patnala, K., Vishwas, S., & Malla, R. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822009-2.00017-0 · Cited by 4
Applications of Starch Debranching Enzymes in Starch Processing
Su, L., & Wu, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-7026-9_7 · Cited by 4
Recent progress in gold and silver nanoparticle mediated drug delivery to breast cancers
Malik, P., Inwati, G. K., Gupta, R., & Mukherjee, T. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99454-5.00012-3 · Cited by 4
Dendrimers: A Lipid-Based Drug Delivery System
Basu, B., Dutta, A., Ash, D., Prajapati, B. G., & Garalae, K. (2023) · doi:10.1201/9781003459811-9 · Cited by 4
Sehnem, E. J., Silva, B. L., Dalmolin, C., & Coelho, L. A. F. (2025) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-025-03633-7 · Cited by 4
Mandadi, S. R., & Srinivas, L. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s06.156 · Cited by 3
Nanocomposites in drug delivery: Advancements and applications
Thakre, D., Vaidya, S., Agrawal, S. S., & Waghe, P. U. (2024) · AIP conference proceedings · doi:10.1063/5.0240242 · Cited by 3
Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer
Modirrousta, Y., & Akbari, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13209-4.00021-0 · Cited by 1
Sharma, A., Modgil, M., Joshi, G., & Bisht, P. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096323618240911140624 · Cited by 1
Therapeutic Translational Potential of Surface-Decorated Nanoparticles
Mishra, N., Nisha, R., Ravi Raj, K. G., Alka, P., Singh, P., Singh, N., & Saraf, S. A. (2023) · CRC Press eBooks · doi:10.1201/9781003220404-39 · Cited by 1
Innovative Drug Delivery Systems for Drug-Resistant Breast Cancer
Mbodi, L., Kgomo, K. A., Grech, G., & Dlamini, Z. (2024) · Springer eBooks · doi:10.1007/978-3-031-52860-6_14 · Cited by 1
Flagged first, then by citations
7 of the 343 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- Arshad, 2022, Nano-based theranostic platforms for breast cancer: a review of latest advancements, Bioeng. (Basel, Switzerland), 9
- Viegas, 2023, Solid lipid nanoparticles vs. Nanostructured lipid carriers: a comparative review, Pharm. Times, 15, 1593
- Madej, 2022, Polymeric nanoparticles—tools in a drug delivery system in selected cancer therapies, Appl. Sci., 12, 9479, 10.3390/app12199479 · DOI
- Arshad, 2022, Nano-based theranostic platforms for breast cancer: a review of latest advancements, Bioeng, 9, 320
- Qureshi, 2024, “Revolutionizing breast cancer care: cutting-edge breakthroughs and, Future Frontiers in Precision Medicine,”, 115
- Chiara, 2022, “2021-WORLD journal of medical innovations, Available at,” WJMI, 1
- Sadr, 2024, Gold nanobiosensors and Machine Learning: pioneering breakthroughs in precision breast cancer detection, Eur. J. Med. Chem. Reports, 12
- Bolla, 2024, Challenges and opportunities in the development of nanoparticle systems for cancer drug delivery, J Recent Adv Nanomed Nanotech, 1
- Hari, 2022, Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system, Drug Deliv. Transl. Res., 13, 135, 10.1007/s13346-022-01197-4 · DOI
- Bachhav, 2020, vol. 7
Cited by
Sorted by citations
Breast Cancer: Molecular Pathogenesis and Targeted Therapy
Samad, M. A., Ahmad, I., Khan, M. R., Suhail, M., Zughaibi, T. A., Al-Abbasi, F. A., Alhosaini, K. A., Khan, M. S., Kumer, A., & Tabrez, S. S. M. (2025) · MedComm · doi:10.1002/mco2.70404 · Cited by 28
Self-citationKrishnan, A., & Francis, M. A. (2025) · BioNanoScience · doi:10.1007/s12668-025-02237-2 · Cited by 12
Natural-Based Magnetite/Hydroxyapatite/Chitosan Nanocomposite as Effective Drug Delivery Systems
Utami, R., Habani, M. H., Sunaryono, S., Munasir, M., Sani, N. S., Yustanti, E., Tahir, D., & Taufiq, A. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02861-8 · Cited by 9
Radiopaque Silk Sericin Nanoparticles for Computed Tomography Imaging of Solid Tumors
Bhoopathy, J., Vedakumari, S. W., Pravin, Y. R., & Prabhu, A. D. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00230 · Cited by 8
Aneja, P., Guleria, R., & Dahiya, D. P. (2025) · Assay and Drug Development Technologies · doi:10.1089/adt.2025.026 · Cited by 6
Metadata
- Authors
- Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S.
- Affiliations
- King Abdulaziz University (SA)
- Corresponding author
- Tabrez, Shams
- ORCID
- Venue
- European Journal of Medicinal Chemistry Reports
- Publisher
- Elsevier BV
- Published
- 2025-08
- Volume
- 14
- Pages
- 100268
- ISSN
- 2772-4174 (ISSN-L)
- OpenAlex
- W4409392096
- Cited by
- 35
- References
- 343
- Citations by year
- 2026: 21 · 2025: 14
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- European Journal of Medicinal Chemistry Reports (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- King Fahad Medical City
- King Abdulaziz University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- breast cancer, nanomedicine, drug delivery systems, liposomes, nanostructured lipid carriers, polymeric micelles, polymeric nanoparticles, dendrimers, hybrid nanostructures, nanotheranostics, gene delivery, targeted drug delivery, drug resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
